News 6/2/23 – HIStalk
Top News
CMS announces that Medicare Part B will cover the use of FDA-approved monoclonal antibodies to slow the progression of Alzheimer’s disease, but will require doctors to populate patient registries for real-world tracking of…
Continue Reading